Have a personal or library account? Click to login
Beyond the gut - Atypical presentation of Salmonella spp. infection Cover

Beyond the gut - Atypical presentation of Salmonella spp. infection

Open Access
|Jul 2024

References

  1. Kam JC, Abdul-Jawad S, Modi C, Abdeen Y, Asslo F, DePasquale JR, et al. Pleural Empyema due to Group D Salmonella. Case Rep Gastrointest Med. 2012 Sep 29;2012:e524561.
  2. Xaplanteri P, Assimakopoulos SF, Karachalios K, Siagris D, Lekkou A, Anastassiou ED, et al. Pleural empyema due to Salmonella enterica serovar Enteritidis in an immunocompetent elderly patient: a case report. JMM Case Rep. 2016 Aug;3(4):e005051.
  3. Rim MS, Park CM, Ko KH, Lim SC, Park KO. Pleural Empyema Due To Salmonella: A Case Report. Korean J Intern Med. 2000 Jul;15(2):138–41.
  4. Rôlo Silvestre C, Nunes A, Cordeiro RJ, Eusébio J, André N, Falcão T, et al. Salmonella empyema an unusual infection – A case report. IDCases. 2021 Jan 1;24:e01096.
  5. Bretzing D, Lat T, Shakespeare A, Lee M, Surani S, Ghamande S. Nontyphi Salmonella Empyema with Bronchopleural Fistula in a Patient with Human Immunodeficiency Virus. Case Rep Pulmonol. 2018 Jun 12;2018:4761725.
  6. Nath G, Maurya P, Gulati AK. ERIC PCR and RAPD based fingerprinting of Salmonella Typhi strains isolated over a period of two decades. Infect Genet Evol. 2010 May 1;10(4):530–6.
  7. Lussana F, Cattaneo M, Rambaldi A, Squizzato A. Ruxolitinib-associated infections: A systematic review and meta-analysis. Am J Hematol. 2018;93(3):339–47.
  8. McLornan DP, Khan AA, Harrison CN. Immunological Consequences of JAK Inhibition: Friend or Foe? Curr Hematol Malig Rep. 2015 Dec 1;10(4):370–9.
  9. Quintás-Cardama A, Kantarjian H, Cortes J, Verstovsek S. Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond. Nat Rev Drug Discov. 2011 Feb;10(2):127–40.
  10. Schönberg K, Rudolph J, Vonnahme M, Parampalli Yajnanarayana S, Cornez I, Hejazi M, et al. JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms. Cancer Res. 2015 Jun 1;75(11):2187–99.
  11. Heine A, Brossart P, Wolf D. Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis? Blood. 2013 Nov 28;122(23):3843–4.
  12. Awang MS, Bustami Y, Hamzah HH, Zambry NS, Najib MA, Khalid MF, et al. Advancement in Salmonella Detection Methods: From Conventional to Electrochemical-Based Sensing Detection. Biosensors. 2021 Sep 18;11(9):346.
  13. Michael GB, Butaye P, Cloeckaert A, Schwarz S. Genes and mutations conferring antimicrobial resistance in Salmonella: an update. Microbes Infect. 2006 Jun 1;8(7):1898–914.
  14. WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance [Internet]. Available from: https://www.who.int/publications-detail-redirect/9789240093461
DOI: https://doi.org/10.2478/amma-2024-0014 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 87 - 94
Submitted on: May 22, 2024
Accepted on: May 28, 2024
Published on: Jul 3, 2024
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Anca Cighir, Corina Eugenia Budin, Teodora Cighir, Anca Delia Mare, Adrian Man, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.